Use of ventricular enlargement rate in intravenous immunoglobulin treatment of Alzheimer's disease

Details for Australian Patent Application No. 2011240556 (hide)

Owner Baxter Healthcare S.A. Baxter International Inc.

Inventors Relkin, Norman R.

Agent Cullens

Pub. Number AU-B-2011240556

PCT Pub. Number WO2011/130355

Priority 61/323,739 13.04.10 US

Filing date 13 April 2011

Wipo publication date 20 October 2011

Acceptance publication date 21 June 2012

International Classifications

A61B 5/05 Measuring for diagnostic purposes - Measuring for diagnosis by means of electric currents or magnetic fields

Event Publications

19 April 2012 PCT application entered the National Phase

  PCT publication WO2011/130355 Priority application(s): WO2011/130355

21 June 2012 Application Accepted

  Published as AU-B-2011240556

18 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011240585-CQI estimation in a wireless communication network

2011240486-Method for performing localized multihypothesis prediction during video coding of a coding unit, and associated apparatus